Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAkçay Yalbuzdağ, Şeniz
dc.contributor.authorSarıfakıo?lu, Ayşe Banu
dc.contributor.authorİkbali Afşar, Sevgi
dc.contributor.authorÇelik, Canan
dc.contributor.authorCan, Aslı
dc.contributor.authorYeğin, Tuğba
dc.contributor.authorYıldırım Güzelant, Aliye
dc.date.accessioned2022-05-11T14:39:45Z
dc.date.available2022-05-11T14:39:45Z
dc.date.issued2015
dc.identifier.issn1052-3057
dc.identifier.issn1532-8511
dc.identifier.urihttps://doi.org/10.1016/j.jstrokecerebrovasdis.2015.03.007
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8696
dc.description.abstractBackground: In recent years, vitamin D deficiency has been suggested as a risk factor for ischemic stroke and stroke severity in both animal models and clinical studies. In this retrospective study, we investigated the relationship between 25-hydroxyvitamin D [25(OH)D] levels and functional outcomes in stroke patients during neurological rehabilitation program. We also investigated whether there is an association between 25(OH)D levels and cognitive impairment. Methods: The study included the medical records of 120 stroke patients who participated in a neurological rehabilitation program. The motor and cognitive components of the Functional Independence Measurements of all patients at admission and discharge were recorded. The Functional Ambulatory Scale was used to assess motor functional status, and the Turkish-validated version of the minimental state examination test was used to assess cognitive status. Results: A significant correlation was found between 25(OH)D level and cognitive impairment among patients who had ischemic strokes. High levels of 25(OH)D were associated with greater functional gain during the rehabilitation program in both ischemic stroke patients and hemorrhagic stroke patients. Conclusions: High 25(OH)D levels might be associated with greater functional improvement and with less cognitive impairment in stroke patients.en_US
dc.language.isoengen_US
dc.publisherElsevier Science Bven_US
dc.identifier.doi10.1016/j.jstrokecerebrovasdis.2015.03.007
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectStrokeen_US
dc.subjectvitamin Den_US
dc.subjectrehabilitationen_US
dc.subjectcognitive functionen_US
dc.subjectVitamin-D Deficiencyen_US
dc.subject25-Hydroxyvitamin D Predictsen_US
dc.subject1,25-Dihydroxyvitamin D-3en_US
dc.subjectD-Receptoren_US
dc.subjectMessenger-Rnaen_US
dc.subjectNeurotoxicityen_US
dc.subjectExpressionen_US
dc.subjectIschemiaen_US
dc.subjectProtectsen_US
dc.subjectHealthen_US
dc.titleIs 25(OH)D Associated with Cognitive Impairment and Functional Improvement in Stroke? A Retrospective Clinical Studyen_US
dc.typearticleen_US
dc.relation.ispartofJournal of Stroke & Cerebrovascular Diseasesen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Fizik Tedavi ve Rehabilitasyon Ana Bilim Dalıen_US
dc.authorid0000-0002-4003-3646
dc.identifier.volume24en_US
dc.identifier.issue7en_US
dc.identifier.startpage1479en_US
dc.identifier.endpage1486en_US
dc.institutionauthorSarıfakıo?lu, Ayşe Banu
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid35192520400
dc.authorscopusid37077994100
dc.authorscopusid55758320600
dc.authorscopusid55945349000
dc.authorscopusid56601176900
dc.authorscopusid56601470000
dc.authorscopusid56601310900
dc.authorwosidAkcay, Seniz/ABH-7247-2020
dc.authorwosidAfsar, Sevgi Ikbali/E-2103-2019
dc.identifier.wosWOS:000356049000011en_US
dc.identifier.scopus2-s2.0-84930821504en_US
dc.identifier.pmid25922112en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster